£3m NIHR funding boost for digital diagnostics in African healthcare systems
A new £3m NIHR award will see Imperial and 13 institutions collaborate to research and develop digital diagnostics for African healthcare systems.
Omicron infection is a poor booster of COVID-19 immunity
People infected with the Omicron variant show poor immune boosting against future SARS-CoV-2 infection.
10
Imperial experts to develop low-cost digital crop virus sensors with $1m grant
Researchers have received $1million to develop low-cost digital sensors that detect viruses in plants and crops with international partners.
Monkeypox outbreak - an Imperial expert explains
The UK Health Security Agency is investigating four new cases of monkeypox in the UK. There are now a total of six confirmed cases.
Arctic clouds and harnessing light: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Feature
Hepatitis outbreak in children: What do we know so far?
Scientists and healthcare professionals around the world are continuing to investigate a sudden increase in hepatitis cases in children.
1
Six Imperial researchers awarded AMS Fellowships
Six Imperial researchers have been elected to the Fellowship of the Academy of Medical Sciences for their outstanding work in their fields.
Imperial reactor delicensed and viral variants: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
COVID-19 mixed with flu increases risk of severe illness and death
Patients in hospital with both COVID-19 and flu are at much greater risk of severe disease and death, research shows.
Aspirin may improve 3-month survival for patients critically ill with COVID-19
Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months.
